A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

NCT00338143 ·Status: COMPLETED ·Phase: PHASE3

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

NCT03885089 ·Status: COMPLETED

A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

NCT01177800 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

NCT00687362 ·Status: COMPLETED ·Phase: PHASE2

IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

NCT06049810 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Long-Term Infliximab for Psoriasis (P05319)

NCT00779675 ·Status: COMPLETED

Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

NCT00629772 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)

NCT00686686 ·Status: COMPLETED ·Phase: PHASE3

Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)

NCT00833053 ·Status: TERMINATED ·Phase: PHASE3

Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)

NCT00254982 ·Status: COMPLETED ·Phase: PHASE3

Bimekizumab in Plaque Psoriasis

NCT06336343 ·Status: COMPLETED ·Phase: PHASE4

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

NCT06875934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp

NCT00669214 ·Status: COMPLETED ·Phase: PHASE4

The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)

NCT00251641 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

NCT03364309 ·Status: COMPLETED ·Phase: PHASE3

Psoriasis Longitudinal Assessment and Registry

NCT00508547 ·Status: ACTIVE_NOT_RECRUITING

A Study of Ixekizumab in Participants With Active Psoriatic Arthritis

NCT01695239 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

A Phase 3 Study in Participants With Moderate to Severe Psoriasis

NCT01474512 ·Status: COMPLETED ·Phase: PHASE3

Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis

NCT00001797 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis

NCT05645627 ·Status: COMPLETED ·Phase: PHASE3

PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

NCT00527072 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

NCT02513550 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

NCT01010542 ·Status: TERMINATED ·Phase: PHASE1

Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors

NCT01882439 ·Status: COMPLETED ·Phase: PHASE3